Skip to main content

Table 3 Binary logistic regression analysis of LRP5 and LRP6 SNP genotype and ABM susceptibility

From: LRP5-/6 gene polymorphisms and its association with risk of abnormal bone mass in postmenopausal women

Group

Genotype

OR (95% CI)

P-value

ABM

Control

LRP5-rs41494349

    

 AA

138(83.13)

92(86.79)

1

1.00

 AG

26(15.66)

12(11.32)

1.444(0.512,4.074)

0.487

 GG

2(1.20)

2(1.87)

0.667(0.041,10.928)

0.776

 AG/GG

28(16.87)

14(13.21)

1.333(0.500,3.556)

0.565

 Allele G

30(9.04)

16(7.55)

  

LRP5-rs2306862

    

 CC

108(65.06)

86(81.13)

1

1.00

 CT

50(30.12)

16(15.09)

2.353(1.039,6.186)

0.041*

 TT

8(4.82)

4(3.77)

2.028 (0.375,10.975)

0.412

 CT/TT

28(43.37)

10(18.87)

2.434(1.071,5.531)

0.034*

 Allele T

66(24.10)

24(11.32)

  

LRP6-rs10743980

    

 CC

94(56.63)

70(66.04)

1

1.00

 CT

64(38.55)

32(30.19)

1.489(0.709,3.130)

0.293

 TT

8(4.82)

4(3.77)

1.489(0.258,8.595)

0.656

 CT/TT

72(43.37)

36(33.96)

1.489(0.728,3.045)

0.275

 Allele T

80(24.10)

40(18.87)

  

LRP6-rs2302685

    

 TT

122(73.49)

90(84.91)

1

1.000

 TC

38(22.89)

10(9.43)

2.951(1.030,8.457)

0.044*

 CC

6(3.61)

6(3.77)

0.492(0.079,3.068)

0.492

 TC/CC

40(26.51)

16(15.09)

2.319(0.911,5.898)

0.078

 Allele C

50(15.06)

22(10.38)

  
  1. ABM Abnormal bone mass, OR odds ratio, 95% CI 95% confidence interval, Data were presented as numbers (proportions)for categorical variables
  2. Adjusted for age and menopausal years
  3. Italicized value is statistically significant, *P < 0.05 indicates statistical significance